why choose us

First received: September 29, 2022

Clinical Trial: PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Gastric Cancer

Study Type: INTERVENTIONAL


Official Title: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Systemic Chemotherapy as a First-line Treatment for Gastric Cancer Peritoneal Metastases: Open-label, Single-arm, Multi-center Feasibility

Brief Summary: Peritoneum is among the most common sites of metastases in gastric cancer.Systemic chemotherapy is the current standard for peritoneal carcinomatosis (PC), although, the treatment results remain extremely poor.Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a modern treatment modality for PC, that 1) optimize the drug distribution by applying an aerosol rather than a liquid solution; and 2) apply increased intraperitoneal hydrostatic pressure to increase drug penetration to the target.Despite some…

Read more